Association between virus-specific cytotoxic T-lymphocyte and helper responses in human immunodeficiency virus type 1 infection
- PMID: 10400769
- PMCID: PMC112756
- DOI: 10.1128/JVI.73.8.6715-6720.1999
Association between virus-specific cytotoxic T-lymphocyte and helper responses in human immunodeficiency virus type 1 infection
Abstract
Cellular immune responses are thought to be an important antiviral host defense, but the relationship between virus-specific T-helper and cytotoxic-T-lymphocyte (CTL) responses has not been defined. To investigate a potential link between these responses, we examined functional human immunodeficiency virus type 1 (HIV-1)-specific memory CTL precursor frequencies and p24-specific proliferative responses in a cohort of infected untreated persons with a wide range of viral loads and CD4 cell counts. Levels of p24-specific proliferative responses positively correlated with levels of Gag-specific CTL precursors and negatively correlated with levels of plasma HIV-1 RNA. These data linking the levels of HIV-specific CTL with virus-specific helper cell function during chronic viral infection provide cellular immunologic parameters to guide therapeutic and prophylactic vaccine development.
Figures
Similar articles
-
Gag-specific immune responses after immunization with p17/p24:Ty virus-like particles in HIV type 1-seropositive individuals.AIDS Res Hum Retroviruses. 1997 Mar 20;13(5):393-9. doi: 10.1089/aid.1997.13.393. AIDS Res Hum Retroviruses. 1997. PMID: 9075480 Clinical Trial.
-
Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia.Science. 1997 Nov 21;278(5342):1447-50. doi: 10.1126/science.278.5342.1447. Science. 1997. PMID: 9367954
-
Reconstitution of virus-specific CD4 proliferative responses in pediatric HIV-1 infection.J Immunol. 2003 Dec 15;171(12):6968-75. doi: 10.4049/jimmunol.171.12.6968. J Immunol. 2003. PMID: 14662905
-
Virus-specific cytotoxic T lymphocyte responses in patients infected with the human immunodeficiency virus, HIV-1.Cell Mol Biol (Noisy-le-grand). 1994;40 Suppl 1:45-8. Cell Mol Biol (Noisy-le-grand). 1994. PMID: 7950861 Review.
-
The role of CD4(+) T helper cells in the cytotoxic T lymphocyte response to HIV-1.Curr Opin Immunol. 2000 Aug;12(4):375-80. doi: 10.1016/s0952-7915(00)00103-5. Curr Opin Immunol. 2000. PMID: 10899028 Review.
Cited by
-
Engineering T Cells to Functionally Cure HIV-1 Infection.Mol Ther. 2015 Jul;23(7):1149-1159. doi: 10.1038/mt.2015.70. Epub 2015 Apr 21. Mol Ther. 2015. PMID: 25896251 Free PMC article. Review.
-
Identification of dominant optimal HLA-B60- and HLA-B61-restricted cytotoxic T-lymphocyte (CTL) epitopes: rapid characterization of CTL responses by enzyme-linked immunospot assay.J Virol. 2000 Sep;74(18):8541-9. doi: 10.1128/jvi.74.18.8541-8549.2000. J Virol. 2000. PMID: 10954555 Free PMC article.
-
Comparison of human immunodeficiency virus antigens as stimulants for lymphocyte proliferation assays.Clin Diagn Lab Immunol. 2002 May;9(3):525-9. doi: 10.1128/cdli.9.3.525-529.2002. Clin Diagn Lab Immunol. 2002. PMID: 11986255 Free PMC article.
-
Focusing HIV-1 Gag T cell responses to highly conserved regions by DNA vaccination in HVTN 119.JCI Insight. 2024 Aug 1;9(18):e180819. doi: 10.1172/jci.insight.180819. JCI Insight. 2024. PMID: 39088271 Free PMC article. Clinical Trial.
-
Multiple effector functions mediated by human immunodeficiency virus-specific CD4(+) T-cell clones.J Virol. 2001 Oct;75(20):9771-9. doi: 10.1128/JVI.75.20.9771-9779.2001. J Virol. 2001. PMID: 11559810 Free PMC article.
References
-
- Brander C, Hartman K E, Trocha A K, Jones N G, Johnson R P, Korber B, Wentworth P, Buchbinder S P, Wolinsky S, Walker B D, Kalams S A. Lack of strong immune selection pressure by the immunodominant, HLA-A*0201-restricted cytotoxic T lymphocyte response in chronic human immunodeficiency virus-1 infection. J Clin Invest. 1998;101:2559–2566. - PMC - PubMed
-
- Carmichael A, Jin X, Sissons P, Borysiewicz L. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease. J Exp Med. 1993;177:249–256. - PMC - PubMed
-
- de St. Groth F. The evaluation of limiting dilution assays. J Immunol Methods. 1982;49:R11–R23. . (Review.) - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials